STACI GATHRIGHT: Open Payments
NPI 1023254257 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 48 payments from 17 companies in 2025. Trend: 2023 $477 · 2024 $759 · 2025 $831
Food & beverage: $831
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $261 |
| PFIZER INC. | 14 | $215 |
| Amgen Inc. | 3 | $44 |
| Novo Nordisk Inc | 3 | $43 |
| SANOFI PASTEUR INC. | 2 | $35 |
| Dynavax Technologies Corporation | 2 | $33 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 2 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: QULIPTA, NURTEC ODT, UBRELVY, PREVNAR 20, OTEZLA, Heplisav-B, TRELEGY ELLIPTA, Ozempic.
Industry payments across AR — which companies pay providers there.
